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IL18 polarizes T H 1 cells 1,2 and induces the production of inflammatory cytokines, chemokines and vascular adhesion molecules 2, [6] [7] [8] . Earlier studies with mice deficient in IL18 (Il18 −/− ) or its receptor IL18r (Il18r −/− ) have demonstrated the contribution of IL18 to several inflammatory diseases [9] [10] [11] . Atherosclerotic lesions, but not normal human aorta, express high levels of IL18 and IL18r in macrophages, T cells, endothelial cells and smooth-muscle cells (SMCs) 12, 13 . In atherosclerosis-prone apolipoprotein E-deficient (Apoe −/− ) mice, the absence of IL18 or blockade of IL18 signaling reduces atherosclerosis and lesion inflammation 3, 4 . Moreover, intraperitoneal administration of IL18 in Apoe −/− mice enhances lesion burden and inflammation 14, 15 . IL18r is a heterodimer consisting of an α-chain for ligand binding and a β-chain responsible for signaling 16 . The absence of IL18r leads to reduced NK cell IFN-γ production and impaired T H 1 cell signaling and differentiation 17 .
When we tested the effects of IL18r deficiency on atherosclerosis, we unexpectedly found that Apoe −/− and Apoe −/− Il18r −/− littermates showed no differences in atherogenesis. In these mice, the presence or absence of IL18r did not affect aortic root intimal area, nor did it affect lesion macrophage, CD4 + T-cell or SMC contents (Fig. 1a) . These results suggest that IL18 acts on target cells in a manner that is independent of, or in addition to, its effects on IL18r. Mouse endothelial cells from Apoe −/− and Apoe −/− Il18r −/− mice showed no differences in cell surface IL18 binding, as assessed by incubation with biotinylated IL18; in both cases, binding could be competed away with a 5-to 10-fold excess of unlabeled IL18 (Fig. 1b) . Endothelial cells from Apoe −/− and Apoe −/− Il18r −/− mice showed a similar pattern of protein tyrosine phosphorylation after 30 min of incubation with active IL18, but not heat-inactivated IL18, as detected by immunoblotting with anti-phosphotyrosine (anti-p-Tyr) antibody (Fig. 1c) . These data point to the presence of alternative molecules that mediate cell-surface IL18 binding and downstream signaling.
To identify possible cell-surface IL18-binding molecules, we incubated endothelial cells from Apoe −/− Il18r −/− mice with IL18 for Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter 15 min and then immunoprecipitated lysates of these cells with an anti-mouse IL18 polyclonal antibody. In sequential eluates, two major bands in the size range of 80-150 kDa were detected by silver-stained SDS-PAGE (Fig. 1d) . Mass spectrometry analysis of these bands identified the 125-kDa Na-Cl co-transporter (NCC), in addition to multiple matrix protein fragments (data not shown).
NCC is a plasma membrane ion co-transporter expressed as a homodimer in kidney distal convoluted tubules, where it participates in electrolyte homeostasis 18 . Other tissues express low levels of NCC 5, 19 . By RT-PCR, we detected abundant NCC mRNA in mouse kidney, but also low levels in the heart, lung and liver ( Supplementary  Fig. 1 ). Immunostaining using an anti-human/mouse NCC polyclonal antibody revealed no NCC expression in normal human or mouse aorta (Fig. 2a) , but abundant NCC expression in human fatty streaks ( Supplementary Fig. 2 ) and advanced atherosclerotic lesions (Fig. 2b) , localized to areas positive for IL18r and CD68 + macrophages. We detected NCC expression in kidney distal tubules from Apoe −/− mice, but not in those from Apoe −/− Ncc −/− (formally, Apoe −/− Slc12a3 −/− ) mice, confirming the specificity of the NCC polyclonal antibody (Supplementary Fig. 3 ). In atherosclerotic lesions from Apoe −/− mice, macrophages, SMCs and endothelial cells expressed NCC (Fig. 2c) , and immunofluorescence staining confirmed colocalization of NCC and IL18r in these cell types (Fig.  2d) . In mouse peritoneal macrophages, IL18 induced NCC expression by 65-fold, as assessed by RT-PCR, but had negligible effects on NCC expression in T cells (Fig. 2e) . However, immunostaining revealed induction of NCC by IL18 in both macrophages and T cells isolated from Apoe −/− mice (Fig. 2e) . IL18, IL1β or TNF-α increased NCC expression in endothelial cells and SMCs from WT mice, as assessed by immunoblotting; the NCC bands detected had the same molecular weights as those detected in NCC/pcDNA3.1-transfected COS-7 cells (see below) (Fig. 2f) . IL18 treatment of peritoneal macrophages isolated from Apoe −/− mice, but not from Apoe −/− Ncc −/− mice, led to enhanced formation of complexes between IL18r and NCC, as assessed by immunoprecipitation with mouse anti-mouse IL18r followed by immunoblotting with the rabbit anti-mouse NCC (Fig. 2g) .
To study the interaction between NCC and IL18, we subcloned full-length mouse NCC cDNA into the pcDNA3.1 vector. On immunoblots, mouse NCC in NCC-transfected COS-7 cells was detected as a doublet band of molecular weights ~125-kDa ( Supplementary Fig. 4) ; the doublet results from differential protein glycosylation 18 . FACS analysis demonstrated surface binding of biotin-conjugated IL18, but not heat-inactivated biotin-IL18, on NCC-transfected COS-7 cells, which did not express IL18r in either the presence or the absence of IL18 (data not shown), 30 min after addition of the ligand (Fig. 2h,  left) . FITC-conjugated IL18 showed a binding affinity (dissociation constant K d = 17.3 nM) to NCC-transfected COS-7 cells (Fig. 2h , middle) that was higher than the previously reported IL18 binding affinity to IL18r-transfected COS-1 cells (K d = 46 nM) 16 . Treatment with IL18, but not heat-inactivated IL18, for 30 min also increased protein tyrosine phosphorylation in NCC-transfected COS-7 cells as compared with empty vector-transfected cells (Fig. 2h, right) , indicating that IL18 interacts with NCC and has effects on signaling.
The insignificant differences in atherogenesis between Apoe −/− and Apoe −/− Il18r −/− mice (Fig. 1a) and the ability of IL18 to bind to NCC-transfected COS-7 cells and elicit cell signaling (Fig. 2h) suggest that NCC mediates the effects of IL18 in atherogenesis in either the presence or the absence of IL18r. To test this hypothesis, we crossbred NCC-deficient mice (Ncc −/− , on a C57BL/6/129S background) 20 with Apoe −/− and Il18r −/− mice to generate Apoe −/− Ncc −/− , Apoe −/− Il18r −/− and Apoe −/− Ncc −/− Il18r −/− littermate mice; we confirmed the genetic background of these mice as C57BL/6/129S by genome scanning analysis (data not shown). Compared with Apoe −/− and Apoe −/− Il18r −/− mice (Fig. 1a) , Apoe −/− Ncc −/− mice showed no significant differences in aortic root atherosclerotic lesion intima area and thoracic-abdominal aorta lipid deposition; we did not characterize lesions from the aortic arches. In contrast, aortic root intimal size was significantly smaller (P < 0.001) and thoracic-abdominal aorta lipid deposition was significantly decreased (P < 0.002) in Apoe −/− Ncc −/− Il18r −/− mice (Fig. 3a,b) (Fig. 3c,d ). Lesion CD4 + T cell numbers did not differ among the groups (Fig. 3c) . Compared with that in Apoe −/− mice, aortic root lesion lipid deposition was nonsignificantly decreased in Apoe −/− Il18r −/− mice (P = 0.079) but significantly decreased in Apoe −/− Ncc −/− (P < 0.02) and in Apoe −/− Ncc −/− Il18r −/− mice (P < 0.003) (Fig. 3e) .
We further tested the concept that a modulatory role for IL18 in atherosclerosis is mediated by IL18r and NCC by inactivating NCC with a thiazide diuretic (hydrochlorothiazide). Thiazide treatment reduced aortic root lesion intima area, lesion macrophage and MHC-II contents in Apoe −/− Il18r −/− but not Apoe −/− mice ( Supplementary  Fig. 5a ). Thiazide showed no effect on lesion CD4 + T cell content (Supplementary Fig. 5a ).
Consistent with prior observations 14, 15 , IL18 administration to Apoe −/− mice enhanced atherogenesis, resulting in increased intima size and lesion macrophage and MHC-II content, although IL18 did not affect lesion T cell number (Supplementary Fig. 5b ). In contrast, IL18 lacked these effects in Apoe −/− Ncc −/− Il18r −/− mice (Supplementary Fig. 5b ). Prior studies 3 Fig. 6 ). Apoe −/− Ncc −/− Il18r −/− mice, however, had significantly higher plasma HDL (P < 0.003) and lower LDL (P = 0.025) than Apoe −/− mice ( Supplementary Fig. 6 ).
In humans and mice, defective NCC function leads to hypomagnesemia, hypokalemia or metabolic alkalosis 21, 22 , kidney tubular disorders that can influence atherosclerosis indirectly 23 . Reduced atherosclerosis in Apoe −/− Ncc −/− Il18r −/− mice may reflect a lack of IL18 function that is not limited to effects on the plaque itself. Apoe −/− Ncc −/− (P < 0.001) and Apoe −/− Ncc −/− Il18r −/− (P < 0.001) mice both had significantly lower plasma Mg 2+ levels than Apoe −/− mice, whereas only Apoe −/− Ncc −/− Il18r −/− mice (P = 0.005) had significantly lower plasma K + levels (Supplementary Fig. 7 ). Plasma pH did not differ among the four groups of mice (Supplementary Fig. 7) . Apoe −/− and Apoe −/− Ncc −/− mice had similar atherosclerotic lesion size (Fig. 3a,b) , arguing against the confounding effects of hypomagnesemia or metabolic alkalosis on atherosclerosis in Apoe −/− Ncc −/− Il18r −/− mice. A possible effect of hypokalemia on atherosclerosis remains unknown.
To test further whether reduced atherosclerosis in Apoe −/− Ncc −/− Il18r −/− mice could be due to electrolyte disturbances, we performed bone marrow transplantation (BMT). In Apoe −/− Ncc −/− Il18r −/− recipient mice, BMT from Apoe −/− Ncc −/− Il18r −/− mice resulted in significantly smaller aortic root intima areas (P = 0.002), thoracic-abdominal aorta lipid deposition (P = 0.024), aortic root lesion macrophage (P = 0.009) and lipid (P = 0.02) content and plasma total cholesterol (P = 0.046) and LDL (P = 0.04) levels, as compared to BMT from Apoe −/− or Apoe −/− Il18r −/− mice. However, there were no significant differences in aortic root lesion T cell number, MHC class II-positive area, SMC content, or plasma K + , Mg 2+ or pH among the groups of Apoe −/− Ncc −/− Il18r −/− recipient mice ( Fig. 3a-e; Supplementary  Figs. 6 and 7) . These observations suggest that reduced atherosclerosis in Apoe −/− Ncc −/− Il18r −/− mice is due to IL18r-and NCCmediated IL18 activation of bone marrow-derived leukocytes and possibly vascular cells, rather than to kidney tubular disorders or electrolyte disturbances.
IL18 induces cytokine expression in inflammatory diseases 2, 3, 6, 15 . Serum IL18 levels in human subjects with atherosclerosis correlate with carotid intima thickness and other biomarkers of inflammation 24, 25 . Compared with Apoe −/− mice, Apoe −/− Ncc −/− Il18r −/− mice showed a greater reduction in the levels of plasma IFN-γ, IL6 and IL18 than did Apoe −/− Il18r −/− or Apoe −/− Ncc −/− mice, although Apoe −/− Il18r −/− and Apoe −/− Ncc −/− mice also had lower levels of plasma IL6 and/or IL18 than did Apoe −/− mice (Fig. 3f) . These findings suggest that both IL18r and NCC contribute to IL18-induced cytokine production. BMT experiments using Apoe −/− Ncc −/− Il18r −/− recipient mice supported this hypothesis. Apoe −/− Ncc −/− Il18r −/− recipient mice receiving bone marrow from Apoe −/− Ncc −/− Il18r −/− mice showed significantly lower plasma IFN-γ (P = 0.026), IL6 (P = 0.012) and IL18 (P = 0.004) than did mice receiving bone marrow from Apoe −/− or Apoe −/− Il18r −/− mice (Fig. 3f) . Although the T cell content of lesions did not differ among the different groups of untransplanted or Apoe −/− Ncc −/− Il18r −/− -transplanted mice (Fig. 3c) , we found in subsequent experiments that both IL18r and NCC mediate IL18-induced IFN-γ and IL6 production in T cells. IL18, with or without IL12, which augments IL18 actions by inducing targeting cell IL18r expression and T H 1 cell differentiation 6, 26 , induced IFN-γ and IL6 expression in T cells from Apoe −/− mice (Fig. 3g) . This induction was diminished in T cells from Apoe −/− Ncc −/− or Apoe −/− Il18r −/− mice, and was further diminished in T cells from Apoe −/− Ncc −/− Il18r −/− mice (Fig. 3g) .
Macrophages also elaborate circulating cytokines. Recombinant IL18 promotes atherogenesis and enhances circulating cytokine levels in the absence of T cells 14, 15 . Macrophages expressed IL18r 12,13 and NCC (Fig. 2b-e) in atherosclerotic lesions or after stimulation with inflammatory mediators. NCC may mediate the effects of IL18 on macrophages in the absence of IL18r, and vice versa. FITC-conjugated IL18 binding to macrophages from Apoe −/− Il18r −/− mice, presumably mediated by NCC, showed a binding affinity (K d = 21.39 nM) (Fig. 4a) similar to that of IL18 to IL18r on human lymphoma L428 *** *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001 27, 28 . However, macrophages from Apoe −/− Ncc −/− Il18r −/− mice exposed to IL18 showed neither ERK1/2 nor p38 phosphorylation (Fig. 4b) , suggesting that IL18r and NCC cooperatively mediate IL18 binding and cell signaling. Moreover, IL18 increased the mRNA (Supplementary Fig. 8 ) and culture medium protein (Fig. 4c,d) (Fig. 4d) . Hydrochlorothiazide also reduced ERK1/2 phosphorylation in IL18-treated macrophages from Apoe −/− Il18r −/− mice, but had negligible effects in cells from Apoe −/− mice (Fig. 4d) . STE20/SPS-1-related proline-alanine-rich protein kinase (SPAK) can activate NCC 29 . IL18 induced SPAK phosphorylation in macrophages from Apoe −/− , Apoe −/− Ncc −/− and Apoe −/− Il18r −/− mice, but not in cells from Apoe −/− Ncc −/− Il18r −/− mice (Fig. 4e) . Therefore, both NCC and IL18r mediate IL18-induced SPAK phosphorylation. The differences in IL18-induced cytokine expression in macrophages from the four groups of mice (Fig. 4c,d ) was specific to IL18 treatment, as macrophage IL6 production in response to TGF-β1 did not vary among the groups (data not shown).
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In NCC-transfected COS-7 cells, which do not express IL18r, treatment with IL18, with or without IL12, provided further evidence that NCC contributes to IL18 signaling and inflammatory cytokine production. NCC overexpression may affect cell volume 30 and intracellular Cl − levels 31 , and thereby affect cell signaling independent of IL18 binding 31, 32 . NCC overexpression in COS-7 cells resulted in an enlarged cell volume (P = 0.003), but did not change intracellular Cl − concentrations before or after NaCl addition (Supplementary Fig. 9 ), suggesting the integrity of NCC-expressing COS-7 cells 33 . This increased cell volume may contribute to the higher baseline phosphorylation of the transcription factor STAT-3 (ref. 34 ) and p38 MAPK observed in NCC-transfected COS-7 cells as compared to vectortransfected COS-7 cells (Fig. 4f) . In NCC-but not vector-transfected cells, IL18 treatment, with or without IL12, induced phosphorylation of STAT-3 and p38 within 15-30 min (Fig. 4f) . Next, we generated and expressed in COS-7 cells three NCC point mutants with amino acid substitutions at its N-terminal phosphorylation sites 31 -T53A, T58A, S71A-and one compound mutant, T53A-T58A-S71A. IL18-induced ERK1/2 phosphorylation was substantially reduced in T53A NCC-and T53A-T58A-S71A NCC-transfected COS-7 cells, but not in T58A NCC-or S71A NCC-transfected cells (Fig. 4g) , supporting a prominent role of the N-terminal Thr 53 of NCC in mediating IL18 signaling.
To test further the role of IL18 in NCC activation, we generated several NCC mutants that have been identified in human subjects with Gitelman syndrome, including G439S, S475C, E121D and Q1030R; each of these mutants leads to impaired thiazide-sensitive Na + uptake or cell membrane targeting 35, 36 . WT and G439S-transfected COS-7 cells had comparable IL18-induced p-ERK1/2 levels, whereas S475C-and E121D-transfected cells had enhanced IL18-induced p-ERK1/2 levels, and Q1030R-transfected cells had decreased IL18-induced p-ERK1/2 levels (Fig. 4h) , consistent with the cell membrane targeting profiles of these mutants 35, 36 .
Phosphorylated NCC was present in whole cell lysates and cell membrane preparations of IL18-stimulated NCC-transfected COS-7 cells, as assessed by immunoblotting using anti-p-NCC polyclonal antibody 37 (Fig. 4i) , demonstrating the presence of functional NCC on the plasma membrane. NCC-transfected COS-7 cells elaborated IL6 after stimulation with IL18 with or without IL12 for 2 d (Fig. 4j,  left) , which is consistent with the cell signaling data presented above (Fig. 4f-i) . In contrast, vector-transfected COS-7 cells did not release IL6 after IL18 treatment alone, and released significantly less IL6 (P < 0.001) than did NCC-transfected cells after treatment with both IL18 and IL12 (Fig. 4j, left) . In NCC-transfected COS-7 cells, in which we co-transfected a pcDNA3.1 construct encoding Flag-tagged mouse IL18r accessory protein (IL18rap), we did not detect an association between NCC and IL18rap with or without IL18 treatment, as assessed in anti-Flag antibody immunoprecipitates (Supplementary Fig. 10) . We further explored the effects of IL18 on NCC using a previously established FlpIn-293 cell line that expresses a full-length mouse NCC cDNA under the control of a tetracycline-inducible promoter 37 but does not express IL18r (data not shown). Active IL18, but not heat-inactivated IL18, induced expression of both total and phosphorylated NCC in FlpIn-293 cells exposed to tetracycline, as detected by immunoblotting (Fig. 4j, middle and right) . Taken together, these results indicate that IL18-induced NCC phosphorylation, downstream signaling and cytokine production require neither IL18r nor the association of NCC with IL18rap.
In the kidney, NCC localizes primarily to distal tubular epithelial cells 38 and contributes to NaCl reuptake. Tubular epithelial cells, glomerular parietal cells, mesangial cells and endothelial cells can express IL18r 39 , which can promote glomerulonephritis by regulating inflammatory cell infiltration, IgG and complement deposition and inflammatory cytokine production 12, 40 . NCC and IL18r therefore have distinct roles in the kidney.
This study demonstrates that IL18r and NCC coordinately participate in atherosclerosis and that these IL18-binding proteins colocalize in vascular SMCs, endothelial cells and macrophages. IL18r and NCC may mediate IL18 signaling independently 16 or as a complex, although informatics searches did not reveal sequence similarity between the intracellular domains of NCC and those of conventional cytokine receptors (data not shown). IL18-mediated NCC activation may also activate downstream cell signaling via increased cell volume or changes in intracellular Cl − concentrations 31, 32 . This study does not exclude the involvement of additional cell membrane or extracellular proteins in the interaction between IL18 and NCC. IL18 may contribute to atherogenesis in part by activating macrophages, T cells, and possibly other inflammatory cells, such as mast cells and neutrophils, to produce IFN-γ, IL6, IL18 and other untested inflammatory cytokines. As indicated by our BMT experiments, the effects of NCC activity in regulating ion flux in the kidney may have a negligible influence on atherogenesis. Under inflammatory conditions, other organs may express high levels of NCC, which, as in atherogenesis, may act alongside IL18r to mediate IL18 activity.
METHOdS
Methods and any associated references are available in the online version of the paper. Cloning and expression of mouse and human wild-type and mutant NCC and IL18rap. A full-length wild-type (WT) mouse NCC cDNA fragment was amplified from mouse endothelial RNA using RT-PCR, using a forward primer covering the start codon and a reverse primer covering the stop codon (NM_019415). Full-length cDNA was subcloned into pcDNA3.1 (Invitrogen). NCC/pcDNA3.1 and empty vector constructs were used for COS-7 cell (American Type Culture Collection, Manassas, VA) transfection with Lipofectamine (Invitrogen). Using NCC/pcDNA3.1 as a template, sitedirected mutagenesis was performed to replace each of three residues located in the NH 2 -terminus of NCC that are sites of phosphorylation (Thr 53 , Thr 58 , and Ser 71 ), or all three amino acids together, with alanine (GenScript USA Inc., Piscataway, NJ). A full-length mouse IL18rap cDNA with a Flag tag at the COOH-terminus (Bioclone, Inc., San Diego, CA) was subcloned into the same pcDNA3.1 expression vector. Human NCC cDNA 47 was subcloned into the pCI-neo vector (Promega), and site-directed mutagenesis was used to generate G439S, S475C, E121D, and Q1030R mutants, followed by Lipofectamine-mediated transfection into COS-7 cells.
Flow cytometry. Recombinant mouse IL18 (MBL International, Woburn, MA) was biotinylated with an EZ-link biotinylation kit (Pierce, Rockford, IL) according to the manufacturer's instructions. Endothelial cells isolated from 6-to 8-week-old Apoe −/− and Apoe −/− Il18r −/− mice or COS-7 cells transfected with NCC/pcDNA 3.1 were incubated with 10 ng/ml biotin-IL18, in the absence or presence of unlabeled IL18, for 10 or 30 min at 37 °C, followed by incubation with 1:100 diluted PE-conjugated streptavidin (#562284, Pharmingen). After three washes, cells were subjected to flow cytometric analysis.
Immunoblotting, RT-PCR, ELISA, and cell volume measurement.
To detect protein tyrosine phosphorylation, mouse endothelial cells, COS-7 cells transfected with wild-type or mutant NCC, or macrophages were starved overnight and then treated with or without IL18, heat-inactivated IL18 (50 to100 ng/ml, or IL12 (10 ng/ml) (PeproTech) for 15 to 30 min. Equal amounts of protein from each cell-type preparation were separated by SDS-PAGE, blotted, and detected with different antibodies, including p-Tyrosine (1:1,000, #309302, BioLegend, San Diego, CA); p-p38 MAPK (Thr 180 /Tyr 182 , #4511, 1:1,000), p-ERK (p-p44/42 MAPK, #9107, 1:1,000) and p-STAT3 (Ser727, #9136, 1:1,000) (Cell Signaling Technology, Inc., Danvers, MA); p-NCC (1:500) 37 and p-SPAK (1:1,000, obtained from the Division of Signal Transduction Therapy Unit at the University of Dundee); and β-actin (1:3,000, #A5441, Sigma). To detect NCC activation in COS-7 cells, we transfected COS-7 cells with pcDNA3.1 or NCC/pcDNA3.1, followed by IL18 (100 ng/ml) treatment for 15 min. Cell membrane and cytosolic fractions were extracted according to the manufacturer's instructions (Fraction PREP cell fractionation kit, BioVision). Equal amounts of protein were separated by SDS-PAGE and detected with polyclonal antibodies to phospho-NCC rabbit 37 and polyclonal antibodies to total NCC (Millipore, 1:1,000). Transfected COS-7 cells were photographed, and cell volumes were measured using computer-assisted analysis (Image-Pro Plus). To express NCC in HEK293 cells, we used the Flp-In T-Rex mammalian expression system (Invitrogen), which permits expression of NCC under the control of a tetracycline-inducible promoter, and which allows NCC to be processed normally by glycosylation and phosphorylation 37 . We transfected HEK293 cells with the NCC construct; the resulting FlpIn-293 cells were maintained in a high-glucose DMEM containing 10% FBS, 200 µg/ml hygromycin, 15 µg/ml blasticidin, and penicillin/streptomycin. To induce NCC expression, we pre-treated the FlpIn-293 cells without or with tetracycline (1 µg/ml) overnight 37 and then with or without IL18 (100 ng/ml) for another overnight incubation, followed by cell lysis and immunoblotting using anti-total-NCC 44 or anti-phospho-NCC 37 rabbit polyclonal antibodies (1:1,000).
To detect NCC in mouse SMCs and endothelial cells, cells were starved overnight and then stimulated with IL18 (50 ng/ml, MBL International), IL1β (10 ng/ml, PeproTech) or TNF-α (10 ng/ml, PeproTech) for 2 days. Immunoblotting was used to detect NCC expression in these cells using rabbit anti-mouse NCC polyclonal antibody (1:1,000, Millipore).
To detect cytokine (IL6 and IFN-γ) and chemokine (MCP-1) expression in CD4 + T cells, peritoneal macrophages, and COS-7 cells, cells were starved overnight and then stimulated with IL18 (50-100 ng/ml, MBL International), IL18 with IL12 (10 ng/ml, PeproTech), hydrochlorothiazide (200 µM, Sigma) 48 , or TGF-β1 (10 ng/ml, R&D Systems) for 2 days. Macrophages were pre-incubated with IL1β and TNF-α for 2 days to induce NCC expression before other treatments. Cytokine and chemokine levels in the culture media were measured with ELISA kits, according to the manufacturer's instructions (R&D Systems). Cells were collected for total RNA preparation and RT-PCR analysis (Bio-Rad, Hercules, CA) to measure IL6, IFN-γ, and MCP-1 mRNA levels.
NCC co-immunoprecipitation with IL18rap and IL18r. Flag-IL18rap and NCC plasmids were transfected into COS-7 cells with Lipofectamine 2000 (Invitrogen). After 48 h, cells were treated with or without IL18 (100 ng/ml) for 15 min and then lysed in RIPA buffer containing 50 mM Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.1% SDS, 5 µg/ml aprotinin, 5 µg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride. An equal amount of protein from each preparation was separated by SDS-PAGE, blotted, and detected with different antibodies, including Flag (1:1,000, clone M2, Sigma), NCC (1:1,000) 37 , and β-actin (A5441, Sigma, 1:3,000). For immunoprecipitation, cell lysates were pre-cleared for 1 h with protein A/G agarose (Santa Cruz Biotechnology Inc., Dallas, TX), followed by overnight incubation with 1 µg anti-Flag antibody (Sigma) and protein A/G agarose for an additional hour. Immunoprecipitates were then washed four times with 1 ml cell lysis buffer, followed by separation on 8% SDS-PAGE for immunoblot analysis with rabbit anti-mouse NCC polyclonal antibody (1:1,000) 37 .
To detect the interaction between NCC and IL18r, we used macrophages from 6-to 8-week-old Apoe −/− and Apoe −/− Ncc −/− mice, instead of attempting to transfect NCC together with all three chains of IL18r into COS-7 cells, which may affect IL18r function. Macrophages were treated with and without IL18 (50 ng/ml, MBL International) for 30 min and cell lysates (300 µg per sample) were immunoprecipitated with rat anti-mouse IL18r monoclonal antibody (clone 112624, R&D Systems) followed by immunoblotting with rabbit anti-NCC polyclonal antibody (Millipore) to detect NCC-IL18r complexes.
IL18 binding and Scatchard plot analysis.
Mouse recombinant IL18 (PeproTech) was conjugated with FITC using a FITC conjugation kit (Sigma). Briefly, IL18 was diluted at 5.0 mg/ml in 0.1 M carbonate-bicarbonate buffer, pH 9.0, and combined with 50 µl of different dilutions (5:1, 10:1, 20:1) of an FITC solution, according to the manufacturer's instructions. Reactions were carried at room temperature in the dark for 2 h. FITC-conjugated IL18 was purified over a Sephadex G-25M column.
The binding assay was performed according to an established protocol from PerkinElmer, Inc. (DELFIA Eu-Labeled IL18). In brief, COS-7 cells or mouse peritoneal macrophages were resuspended in a buffer containing 20 mM HEPES and 10 mM EDTA, pH 7.5, and incubated at 4 °C for 15 min. Cells were then homogenized and centrifuged at 28,000 rpm, at 4 °C for 30 min. The cell pellet was resuspended in a storage buffer containing 20 mM HEPES and 1 mM EDTA, pH 7.5, and rehomogenized with a Polytron PT3100 homogenizer. An equal amount of protein was incubated with FITC-IL18 in a binding buffer (50 mM Tris-HCL, 5 mM MgCl 2 , 25 µM EDTA, 0.2% BSA) for 90 min at room temperature in an AcroWell 96 Filter Plate (Pall Corp., Port Washington, NY). The plate was then washed four times with 50 mM Tris-HCl and 5 mM MgCl 2 . The plate was read with excitation at 494 nm and emission at 518 nm. Scatchard analysis was performed using Prism 3.02 software (GraphPad Software Inc., La Jolla, CA). To test FITC-IL18 binding affinity to NCC on COS-7 cells, which do not express IL18r (data not shown), we used NCC-transfected COS-7 cells. Empty vector-transfected COS-7 cells were used as the background control. To test FITC-IL18 binding affinity to macrophages, we used adhesion depletionpurified peritoneal macrophages from Apoe −/− Il18r −/− mice; cells from Apoe −/− Ncc −/− Il18r −/− mice were used as the background control. Data are presented as the mean of three to five experiments. npg Intracellular chloride measurements. To measure intracellular chloride concentrations, COS-7 cells were transfected with pcDNA3.1 or NCC/pcDNA3.1 for 2 days. Intracellular chloride concentration was then monitored using a chloride-sensitive fluorescent dye, n-(ethoxycarbonylmethyl)-6-methoxyquinolinium (MQAE), as described 33 . Briefly, cells were first incubated with 10 mM MQAE (Invitrogen) in a loading buffer [DMEM, 0.1% BSA, 10 mM 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid (HEPES), pH 7.5] for 45 min at 37 °C. Cells were then washed with DMEM or with chloride-free medium (101 mM sodium gluconate, 5 mM potassium gluconate, 2 mM MgSO 4 , 2 mM calcium acetate, 10 mM HEPES, pH 7.5, 10 mM glucose), and fluorescence was excited at 350 nm and detected at 460 nm. Using a Wallac fluorescence spectrophotometer (PerkinElmer), MQAE fluorescence was monitored over the course of 5 min and then for an additional 5 min after the addition of NaCl (25 mM). Reduction (efflux) of the intracellular chloride concentration is read out as an increase in fluorescence.
Statistical analysis. We used the non-parametric Mann-Whitney test followed by Bonferroni correction to examine the statistical significance between groups, due to the relatively small sample sizes and often skewed distributions. P < 0.05 was considered statistically significant. All data were expressed as mean ± s.e.m. The number of mice in each experimental group was determined by the availability of the mice and our prior experience; we did not perform power calculations. No data points were excluded.
